Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism Tubulin inhibitors, c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC38H54ClN3O10S |
InChIKeyVNWBDUCJQWNNMQ-VCYQDXHBSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - |